Valencia Technologies is a Valencia, CA–based neuromodulation company focused on minimally invasive treatment of urinary incontinence. Its flagship product is the eCoin system, a subcutaneous implantable tibial nerve stimulator for urgency urinary incontinence (UUI), which received FDA approval in 2022. The company manufactures and markets the eCoin system. Valencia announced a strategic investment of up to $35M of committed capital to accelerate commercial growth. The funds were provided by Brooks Advisory Group, an affiliate of Brooks Management Group. The company also appointed James D. Surek as CEO.

Total raised

$35M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2025